Clinical trial
Bevacizumab in Pats w/ Recurrent ST Brain Metas Who Have Failed Whole Brain…
NCT01898130 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT01898130 |
|---|---|
| Title | Bevacizumab in Pats w/ Recurrent ST Brain Metas Who Have Failed Whole Brain Radiation Therapy |
| Official title | A Phase II Trial of Bevacizumab in Patients With Recurrent Solid Tumor Brain Metastases Who Have Failed Whole Brain Radiation Therapy |
| Lead sponsor | Northwestern University, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Biological, Procedure |
| Interventions | bevacizumab, quality-of-life assessment |
| Enrollment | 27 |
| Start date | Nov 27, 2013 |
| Primary completion | Mar 23, 2017 |
| Completion | Sep 5, 2018 |
| First posted | Jul 12, 2013 |
| Last update posted | Sep 17, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: